Group Overview Operation and Financial Review Financials Other Information Sustainability and Governance 67 Annual Report 2025 Consolidated cash flow statement For the financial year ended 31 December 2025 The accompanying accounting policies and explanatory notes form an integral part of the financial statements. Note 2025 2024 Rp million Rp million Cash flows from investing activities Additions to property, plant and equipment (1,130,791) (987,221) Additions to right-of-use assets 15 (38,978) (37,574) Additions to biological assets (306,346) (272,326) Decrease in plasma receivables 32(a) 39,258 15,762 Proceeds from disposal of property, plant and equipment 14 11,101 12,973 Advances for projects and purchases of fixed assets (119,258) (261,068) Dividend received from a joint venture – 92,234 Net cash flows used in investing activities (1,545,014) (1,437,220) Cash flows from financing activities Proceeds from interest-bearing loans and borrowings 12,618,042 3,693,955 Repayment of interest-bearing loans and borrowings (11,189,868) (3,719,140) Dividend payments by subsidiaries to non-controlling interests (267,350) (148,540) Dividend payment to the Company’s shareholders (177,270) (132,838) Payment of lease liabilities 15 (291,601) (47,667) Payment of loan to related parties (298,344) (146,470) Additional capital contribution in subsidiaries by a non-controlling shareholder 322,000 353,040 Net cash flows generated from/(used in) financing activities 715,609 (147,660) Net increase in cash and cash equivalents 2,548,612 640,438 Effect of changes in exchange rates on cash and cash equivalents 79,177 79,532 Cash and cash equivalents at the beginning of the financial year 5,945,500 5,225,530 Cash and cash equivalents at the end of the financial year 25 8,573,289 5,945,500
RkJQdWJsaXNoZXIy NTkwNzg=